Dermabrasion combined with photodynamic therapy: a new option for the treatment of non-melanoma skin cancer
Nianzhou Yu,Xi Luo,Tianhong Wei,Qian Zhang,Jing Yu,Lisha Wu,Juan Su,Mingliang Chen,Kai Huang,Fangfang Li,Yang Xie,Fang Fang,Liang Zhang,Renliang He,Xiang Chen,Shuang Zhao,WenBo Bu
DOI: https://doi.org/10.1007/s10103-021-03381-3
2021-01-01
Lasers in Medical Science
Abstract:Non-melanoma skin cancer (NMSC) is the most common malignancy. Photodynamic therapy (PDT) is effective for the treatment of certain NMSCs. However, the clinical response rates of some NMSCs to single PDT are still far from ideal. The reason may be that PDT has shown limited efficacy in managing thicker NMSCs. To explore the efficacy and safety of dermabrasion combined with PDT (D-PDT) for the treatment of NMSCs. This was a retrospective, single-arm, multi-centre study. In total, 172 tumours from 40 patients were treated with D-PDT during the study period. The mean follow-up period was 40 months (range 15–110 months). D-PDT was performed with 633-nm red light at 80 m W/cm 2 after lesion dermabrasion and 4 h of photosensitizer exposure. Six nodular basal cell carcinomas (nBCCs) from 6 patients, 9 squamous cell carcinomas (SCCs) from 9 patients, 17 Bowen diseases (BDs) from 10 patients and 140 actinic keratoses (AKs) from 15 patients treated with D-PDT were examined in this study. Only two patients with three AKs experienced recurrence over 12 months. The mean final follow-up periods of patients with AKs, BDs, nBCCs and SCCs were 30, 33, 45 and 60 months, respectively. Thirty-four of the 40 patients treated with D-PDT reported excellent or good cosmetic results. The mean Dermatology Life Quality Index (DLQI ) scores of the patients improved significantly after treatment (estimated MD 9.72 [95% CI 8.69 to 10.75]; p < 0.001). D-PDT is a safe, cosmetic and effective treatment that could be a new candidate therapeutic for NMSC.